Literature DB >> 19667851

The United States critical illness and injury trials group: an introduction.

J Perren Cobb1, Charles B Cairns, Eileen Bulger, Hector R Wong, Polly E Parsons, Derek C Angus, Nina T Gentile, David B Hoyt, Debra A Schwinn, Jeanine P Wiener-Kronish, Jeffrey S Upperman.   

Abstract

The US Critical Illness and Injury Trials Group is funded to engage the relevant scientific communities and federal agencies to jointly advocate for clinical research. An inclusive, nationwide network of experts has been created to establish national priorities and pursue a strategic plan in conjunction with professional societies and existing research networks. Investigator-initiated clinical proposals will be presented and discussed at the inaugural National Institutes of Health meeting to promote collaboration and establish working groups to develop projects and core resources. Future US Critical Illness and Injury Trials Group meetings will convene triannually, providing a venue to gauge progress on strategic deliverables, foster development of the clinical projects, discuss education and training in clinical trial design, and address the ethical, legal, and social implications of research in the critically ill or injured patients.

Entities:  

Mesh:

Year:  2009        PMID: 19667851     DOI: 10.1097/TA.0b013e3181ad3473

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  2 in total

1.  United States Critical Illness and Injury Trials Group.

Authors:  James M Blum; Peter E Morris; Greg S Martin; Michelle N Gong; Satish Bhagwanjee; Charles B Cairns; J Perren Cobb
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

2.  Making big data useful for health care: a summary of the inaugural mit critical data conference.

Authors:  Omar Badawi; Thomas Brennan; Leo Anthony Celi; Mengling Feng; Marzyeh Ghassemi; Andrea Ippolito; Alistair Johnson; Roger G Mark; Louis Mayaud; George Moody; Christopher Moses; Tristan Naumann; Marco Pimentel; Tom J Pollard; Mauro Santos; David J Stone; Andrew Zimolzak
Journal:  JMIR Med Inform       Date:  2014-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.